{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:12:39Z","timestamp":1794445959710,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Scientific Research Project of Universities of Henan Education Department","award":["22A320024"],"award-info":[{"award-number":["22A320024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-023-04921-5","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T23:03:11Z","timestamp":1679439791000},"page":"2597-2606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children \u2014 a prospective, randomized, double-masked, and crossover trial"],"prefix":"10.1007","volume":"182","author":[{"given":"Weiqun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aicun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"4921_CR1","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1136\/bmj.324.7347.1195","volume":"324","author":"DR Fredrick","year":"2002","unstructured":"Fredrick DR (2002) Myopia. Br Med J 324:1195\u20131199. https:\/\/doi.org\/10.1136\/bmj.324.7347.1195","journal-title":"Br Med J"},{"key":"4921_CR2","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/aos.12387","volume":"92","author":"O Parssinen","year":"2014","unstructured":"Parssinen O, Kauppinen M, Viljanen A (2014) The progression of myopia from its onset at age 8\u201312 to adulthood and the influence of heredity and external factors on myopic progression. A 23-year follow-up study. Acta Ophthalmol 92:730\u2013739. https:\/\/doi.org\/10.1111\/aos.12387","journal-title":"Acta Ophthalmol"},{"key":"4921_CR3","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamaophthalmol.2020.3451","volume":"138","author":"Y Hu","year":"2020","unstructured":"Hu Y, Ding XH, Guo XX, Chen YX, Zhang J, He MG (2020) Association of age at myopia onset with risk of high myopia in adulthood in a 12-year follow-up of a Chinese Cohort. JAMA Ophthalmol 138:1129\u20131134. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.3451","journal-title":"JAMA Ophthalmol"},{"key":"4921_CR4","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/aos.13964","volume":"97","author":"O Parssinen","year":"2019","unstructured":"Parssinen O, Kauppinen M (2019) Risk factors for high myopia: a 22-year follow-up study from childhood to adulthood. Acta Ophthalmol 97:510\u2013518. https:\/\/doi.org\/10.1111\/aos.13964","journal-title":"Acta Ophthalmol"},{"key":"4921_CR5","doi-asserted-by":"publisher","first-page":"M20","DOI":"10.1167\/iovs.18-25957","volume":"60","author":"DI Flitcroft","year":"2019","unstructured":"Flitcroft DI, He MG, Jonas JB, Jong M, Naidoo K, Ohno-Matsui K, Rahi J, Resnikoff S, Vitale S, Yannuzzi L (2019) IMI - Defining and classifying myopia: a proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci 60:M20\u2013M30. https:\/\/doi.org\/10.1167\/iovs.18-25957","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4921_CR6","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1167\/iovs.06-0562","volume":"48","author":"DO Mutti","year":"2007","unstructured":"Mutti DO, Hayes JR, Mitchell GL et al (2007) Refractive error, axial length, and relative peripheral refractive error before and after the onset of myopia. Invest Ophthalmol Vis Sci 48:2510\u20132519. https:\/\/doi.org\/10.1167\/iovs.06-0562","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4921_CR7","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.ophtha.2012.01.017","volume":"119","author":"F Xiang","year":"2012","unstructured":"Xiang F, He MG, Morgan IG (2012) Annual changes in refractive errors and ocular components before and after the onset of myopia in Chinese children. Ophthalmology 119:1478\u20131484. https:\/\/doi.org\/10.1016\/j.ophtha.2012.01.017","journal-title":"Ophthalmology"},{"key":"4921_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","volume":"33","author":"PC Wu","year":"2019","unstructured":"Wu PC, Chuang MN, Choi J, Chen H, Wu G, Ohno-Matsui K, Jonas JB, Cheung CMG (2019) Update in myopia and treatment strategy of atropine use in myopia control. Eye 33:3\u201313. https:\/\/doi.org\/10.1038\/s41433-018-0139-7","journal-title":"Eye"},{"key":"4921_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.ophtha.2020.10.040","volume":"128","author":"BS Modjtahedi","year":"2021","unstructured":"Modjtahedi BS, Abbott RL, Fong DS, Lum F, Tan D, Task Force M (2021) Reducing the global burden of myopia by delaying the onset of myopia and reducing myopic progression in children the academy\u2019s task force on myopia. Ophthalmology 128:816\u2013826. https:\/\/doi.org\/10.1016\/j.ophtha.2020.10.040","journal-title":"Ophthalmology"},{"key":"4921_CR10","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/apo.0000000000000256","volume":"8","author":"FF Li","year":"2019","unstructured":"Li FF, Yam JC (2019) Low-concentration atropine eye drops for myopia progression. Asia-Pac J Ophthalmol 8:360\u2013365. https:\/\/doi.org\/10.1097\/apo.0000000000000256","journal-title":"Asia-Pac J Ophthalmol"},{"key":"4921_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam JC, Jiang YN, Tang SM et al (2019) Low-concentration atropine for myopia progression (LAMP) study a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Ophthalmology 126:113\u2013124. https:\/\/doi.org\/10.1016\/j.ophtha.2018.05.029","journal-title":"Ophthalmology"},{"key":"4921_CR12","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.ophtha.2019.12.011","volume":"127","author":"JC Yam","year":"2020","unstructured":"Yam JC, Li FF, Zhang XJ et al (2020) Two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) study phase 2 report. Ophthalmology 127:910\u2013919. https:\/\/doi.org\/10.1016\/j.ophtha.2019.12.011","journal-title":"Ophthalmology"},{"key":"4921_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ophtha.2021.10.002","volume":"129","author":"JC Yam","year":"2022","unstructured":"Yam JC, Zhang XJ, Zhang YZ et al (2022) Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout phase 3 report. Ophthalmology 129:308\u2013321. https:\/\/doi.org\/10.1016\/j.ophtha.2021.10.002","journal-title":"Ophthalmology"},{"key":"4921_CR14","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1136\/bjophthalmol-2019-315440","volume":"104","author":"AC Fu","year":"2020","unstructured":"Fu AC, Stapleton F, Wei L, Wang WQ, Zhao BX, Watt K, Ji N, Lyu Y (2020) Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression. Br J Ophthalmol 104:1535\u20131541. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315440","journal-title":"Br J Ophthalmol"},{"key":"4921_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1080\/17425247.2021.1909568","volume":"18","author":"IG Del Valle","year":"2021","unstructured":"Del Valle IG, Alvarez-Lorenzo C (2021) Atropine in topical formulations for the management of anterior and posterior segment ocular diseases. Expert Opin Drug Deliv 18:1245\u20131259. https:\/\/doi.org\/10.1080\/17425247.2021.1909568","journal-title":"Expert Opin Drug Deliv"},{"key":"4921_CR16","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2015.10803","volume":"314","author":"MG He","year":"2015","unstructured":"He MG, Xiang F, Zeng YF, Mai JC, Chen QY, Zhang J, Smith WN, Rose K, Morgan IG (2015) Effect of time spent outdoors at school on the development of myopia among children in China a randomized clinical trial. JAMA-J Am Med Assoc 314:1142\u20131148. https:\/\/doi.org\/10.1001\/jama.2015.10803","journal-title":"JAMA-J Am Med Assoc"},{"key":"4921_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1371\/journal.pone.0140419","volume":"10","author":"HM Huang","year":"2015","unstructured":"Huang HM, Chang DST, Wu PC (2015) The association between near work activities and myopia in children-a systematic review and meta-analysis. PLoS ONE 10:15. https:\/\/doi.org\/10.1371\/journal.pone.0140419","journal-title":"PLoS ONE"},{"key":"4921_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4103\/ijo.IJO_1462_21","volume":"70","author":"J Jethani","year":"2022","unstructured":"Jethani J (2022) Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes. Indian J Ophthalmol 70:238\u2013240. https:\/\/doi.org\/10.4103\/ijo.IJO_1462_21","journal-title":"Indian J Ophthalmol"},{"key":"4921_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/jop.2009.0135","volume":"26","author":"PC Fang","year":"2010","unstructured":"Fang PC, Chung MY, Yu HJ, Wu PC (2010) Prevention of myopia onset with 0.025% atropine in premyopic children. J Ocular Pharmacol Ther 26:341\u2013345. https:\/\/doi.org\/10.1089\/jop.2009.0135","journal-title":"J Ocular Pharmacol Ther"},{"key":"4921_CR20","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1167\/iovs.07-0385","volume":"49","author":"S Hasebe","year":"2008","unstructured":"Hasebe S, Ohtsuki H, Nonaka T, Nakatsuka C, Miyata M, Hamasaki I, Kimura S (2008) Effect of progressive addition lenses on myopia progression in Japanese children: a prospective, randomized, double-masked, crossover trial. Invest Ophthalmol Vis Sci 49:2781\u20132789. https:\/\/doi.org\/10.1167\/iovs.07-0385","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4921_CR21","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ophtha.2014.09.028","volume":"122","author":"HA Swarbrick","year":"2015","unstructured":"Swarbrick HA, Alharbi A, Watt K, Lum E, Kang P (2015) Myopia control during orthokeratology lens wear in children using a novel study design. Ophthalmology 122:620\u2013630. https:\/\/doi.org\/10.1016\/j.ophtha.2014.09.028","journal-title":"Ophthalmology"},{"key":"4921_CR22","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ophtha.2010.10.035","volume":"118","author":"NS Anstice","year":"2011","unstructured":"Anstice NS, Phillips JR (2011) Effect of dual-focus soft contact lens wear on axial myopia progression in children. Ophthalmology 118:1152\u20131161. https:\/\/doi.org\/10.1016\/j.ophtha.2010.10.035","journal-title":"Ophthalmology"},{"key":"4921_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3238\/arztebl.2012.0276","volume":"109","author":"S Wellek","year":"2012","unstructured":"Wellek S, Blettner M (2012) On the proper use of the crossover design in clinical trials part 18 of a series on evaluation of scientific publications. Dtsch Arztebl Int 109:276\u2013281. https:\/\/doi.org\/10.3238\/arztebl.2012.0276","journal-title":"Dtsch Arztebl Int"},{"key":"4921_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3760\/cma.j.cn115989-20210821-00470","volume":"40","author":"SA Yu","year":"2022","unstructured":"Yu SA, Lv Y, Wang WQ, Cui C, Wei L, Huang CC, Ma NN, Zhao BX, Zhang JJ, Fu AC (2022) Effects of 0.01% atropine eye drops on the prevention of myopia onset among schoolchildren: a randomized, double-blind, controlled trial. Chinese J Exp Ophthalmol 40:533\u2013540. https:\/\/doi.org\/10.3760\/cma.j.cn115989-20210821-00470","journal-title":"Chinese Journal of Experimental Ophthalmology"},{"key":"4921_CR25","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ophtha.2010.09.025","volume":"118","author":"JS Rahi","year":"2011","unstructured":"Rahi JS, Cumberland PM, Peckham CS (2011) Myopia over the lifecourse: prevalence and early life influences in the 1958 British Birth Cohort. Ophthalmology 118:797\u2013804. https:\/\/doi.org\/10.1016\/j.ophtha.2010.09.025","journal-title":"Ophthalmology"},{"key":"4921_CR26","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.ophtha.2015.03.018","volume":"122","author":"KM Williams","year":"2015","unstructured":"Williams KM, Bertelsen G, Cumberland P et al (2015) Increasing prevalence of myopia in Europe and the impact of education. Ophthalmology 122:1489\u20131497. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.018","journal-title":"Ophthalmology"},{"key":"4921_CR27","doi-asserted-by":"publisher","unstructured":"Wang M, Cui C, Sui Y, Yu SA, Ma JX, Fu AC (2022) Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial. BMC Ophthalmol 22:9. https:\/\/doi.org\/10.1186\/s12886-022-02385-z","DOI":"10.1186\/s12886-022-02385-z"},{"key":"4921_CR28","doi-asserted-by":"publisher","unstructured":"Cui C, Li XJ, Lyu Y, Wei L, Zhao BX, Yu SA, Rong JB, Bai YH, Fu AC (2021) Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial. Sci Rep 11:8. https:\/\/doi.org\/10.1038\/s41598-021-01708-2","DOI":"10.1038\/s41598-021-01708-2"},{"key":"4921_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41598-021-88719-1","volume":"11","author":"AC Fu","year":"2021","unstructured":"Fu AC, Stapleton F, Li W, Wang WQ, Zhao BX, Watt K, Yu SA, Cui C, Lyu Y (2021) Risk factors for rapid axial length elongation with low concentration atropine for myopia control. Sci Rep 11:7. https:\/\/doi.org\/10.1038\/s41598-021-88719-1","journal-title":"Sci Rep"},{"key":"4921_CR30","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1034\/j.1600-0420.2003.00092.x","volume":"81","author":"R Goyal","year":"2003","unstructured":"Goyal R, North RV, Morgan JE (2003) Comparison of laser interferometry and ultrasound A-scan in the measurement of axial length. Acta Ophthalmol Scand 81:331\u2013335. https:\/\/doi.org\/10.1034\/j.1600-0420.2003.00092.x","journal-title":"Acta Ophthalmol Scand"},{"key":"4921_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1442-9071.2003.00617.x","volume":"31","author":"LT Rose","year":"2003","unstructured":"Rose LT, Moshegov CN (2003) Comparison of the Zeiss IOLMaster and applanation A-scan ultrasound: biometry for intraocular lens calculation. Clin Exp Ophthalmol 31:121\u2013124. https:\/\/doi.org\/10.1046\/j.1442-9071.2003.00617.x","journal-title":"Clin Exp Ophthalmol"},{"key":"4921_CR32","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","volume":"138","author":"SF Wei","year":"2020","unstructured":"Wei SF, Li SM, An WZ, Du JL, Liang XT, Sun YY, Zhang DX, Tian JX, Wang NL (2020) Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children a randomized clinical trial. JAMA Ophthalmol 138:1178\u20131184. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.3820","journal-title":"JAMA Ophthalmol"},{"key":"4921_CR33","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","volume":"119","author":"A Chia","year":"2012","unstructured":"Chia A, Chua WH, Cheung YB, Wong WL, Lingham A, Fong A, Tan D (2012) Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2). Ophthalmology 119:347\u2013354. https:\/\/doi.org\/10.1016\/j.ophtha.2011.07.031","journal-title":"Ophthalmology"},{"key":"4921_CR34","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1136\/bjophthalmol-2015-307861","volume":"100","author":"J Loughman","year":"2016","unstructured":"Loughman J, Flitcroft DI (2016) The acceptability and visual impact of 0.01% atropine in a Caucasian population. Br J Ophthalmol 100:1525\u20131529. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307861","journal-title":"Br J Ophthalmol"},{"key":"4921_CR35","doi-asserted-by":"publisher","unstructured":"Kinoshita N, Konno Y, Hamada N, Kanda Y, Shimmura-Tomita M, Kaburaki T, Kakehashi A (2020) Efficacy of combined orthokeratology and 0.01% atropine solution for slowing axial elongation in children with myopia: a 2-year randomised trial. Sci Rep 10:11. https:\/\/doi.org\/10.1038\/s41598-020-69710-8","DOI":"10.1038\/s41598-020-69710-8"},{"key":"4921_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/opo.12722","volume":"40","author":"Q Tan","year":"2020","unstructured":"Tan Q, Ng ALK, Choy BNK, Cheng GPM, Woo VCP, Cho P (2020) One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial. Ophthalmic Physiol Opt 40:557\u2013566. https:\/\/doi.org\/10.1111\/opo.12722","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04921-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-023-04921-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-023-04921-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T04:03:50Z","timestamp":1686369830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-023-04921-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":36,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["4921"],"URL":"https:\/\/doi.org\/10.1007\/s00431-023-04921-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2314578\/v1","asserted-by":"object"}]},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]},"assertion":[{"value":"26 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Human Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Number: 2020-KY-286).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants and their parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}